NCT06796959 (CD-PET) is a clinical trial in Small Bowel Crohn's Disease, sponsored by Turku University Hospital.

Who is sponsoring NCT06796959?

NCT06796959 is sponsored by Turku University Hospital.

What condition does NCT06796959 study?

NCT06796959 studies Small Bowel Crohn's Disease.

Is NCT06796959 still recruiting?

NCT06796959 is currently completed. Last updated 5 February 2025.

Last reviewed 2025-02-05 · How we verify

NCT06796959: CD-PET

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Combined [18F]-FDG PET-MRI in Diagnostics and Surveillance of Small Bowel Crohn's Disease

Completed Last updated 5 February 2025

What this trial tests

trial in Small Bowel Crohn's Disease in 35 participants. Completed in 31 October 2024.

Timeline

1 August 2020

Primary endpoint
31 October 2024

31 October 2024

Quick facts

Lead sponsor	Turku University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	35
Start date	1 August 2020
Primary completion	31 October 2024
Estimated completion	31 October 2024
Sites	1 location across Finland

Conditions studied

Small Bowel Crohn's Disease — all drugs for Small Bowel Crohn's Disease →

Sponsor

Turku University Hospital

Who can join

Adults 18 to 70, any sex, with Small Bowel Crohn's Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with suspected small bowel Crohn's disease (CD) are assessed with PET-MRE using 18-fluorodeoxyglucose (\[18F\]-FDG) tracer. Patients are recruited from the outpatient clinic of gastroenterology in Turku University Hospital. The patients must fulfil the eligibility criteria and give their signed approvement prior to their enrolment into the study. This is an observational single-center imaging study. 35 patients with high clinical suspicion of active small bowel CD will be enrolled to study. After the diagnostic \[18F\]-FDG-PET-MRE, patients will undergo small bowel capsule endoscopy (SBCE) if no strictures are seen in PET-MRE. \[18F\]-FDG-PET-MRE will be repeated in 3 months after medical therapy for CD has been started. Medical therapy will be started by clinicians blinded from PET-data but have access to MRE-data and all other diagnostic measures. Adequate medication is chosen by clinicians not participating in the study and thus enrollment does not affect the choice of medical therapy for patients participating in this study. \[18F\]-FDG-PET-MRE and clinical assessment of disease activity will be performed within 1 month of recruitment. Follow up-visits will be arranged in the outpatient clinic of gastroenterology in Turku University Hospital. The aim is to investigate whether \[18F\]-FDG-PET-MRE can be used in diagnostics and follow-up of small bowel CD and to compare its performance to MRE.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Combined [<sup>18</sup>F]-FDG PET-MR imaging for monitoring small bowel crohn's disease.
Mattila J, Kallio J, Löyttyniemi E, Nuutila P, et al · · 2026 · PMID 40856818 · DOI 10.1007/s00259-025-07524-4

Verify or expand the search:

Other Turku University Hospital trials

Trials by the same sponsor.

NCT07488494 — Effective Implementation of the Physical Activity and Motor Skills Intervention for 3-6-year-old Children With Cancer (E · NA · not yet recruiting
NCT07316868 — Neuroprotective Effect of Mild Hypothermia Versus Normothermia During Cardiopulmonary Bypass of Coronary Artery Surgery · NA · not yet recruiting
NCT07306000 — Pilot Study: Effects of CCP Intervention on NICU Environment and Preterm Infants Development · NA · recruiting
NCT07272824 — Usability Study of Gestational and Postpartum Weight Management Program · recruiting
NCT07310472 — Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06796959 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Turku University Hospital
Last refreshed: 5 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06796959.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing